Category: Trade Association

340B DSH Hospitals More Likely To Treat Black, Disabled, and Low-Income Patients With Chronic Conditions, Study Indicates

June 4, 2021 Tom Mirga, Editor at Large Views

A new hospital-funded study found that 340B disproportionate share (DSH) hospital outpatient departments are more likely than other hospital outpatient departments and independent physician offices to treat Medicare beneficiaries with chronic conditions who are Black, disabled, or who have low incomes. | Shutterstock

340B disproportionate share (DSH) hospital outpatient departments are more likely than other hospital outpatient departments and independent physician offices to treat Medicare beneficiaries with chronic conditions who are Black, disabled, or who have low incomes, a new 340B hospital-funded study

HHS Asks U.S. Supreme Court to Reject 340B Hospital Request to Hear Medicare Part B Case

May 14, 2021 Ron Shinkman Views

HHS has asked the U.S. Supreme Court to decline taking up 340B hospital suit on Medicare Part B reimbursement.

While 340B hospitals eagerly await to see the Biden administration’s plans for Medicare Part B reimbursement, the U.S. Department of Health and Human Services (HHS) last night asked the U.S. Supreme Court to reject an effort by hospital groups to

Hospital Groups Ask HHS to Start Fining Pharma Over 340B Pricing Denials

April 22, 2021 Tom Mirga, Editor at Large Views

Hospital groups want HHS Secretary Xavier Becerra to impose civil fines on six drug companies for refusing to offer 340B discounts on drugs dispensed by contract pharmacies. | Gage Skidmore

Six hospital groups asked U.S. Health and Human Services (HHS) Secretary Xavier Becerra on Tuesday to state “immediately and definitively” that six drug manufacturers’ refusals to offer 340B discounts on drugs dispensed by contract pharmacies are illegal.

They also asked

Public Relations War Over 340B’s Intent Intensifies

April 20, 2021 Tom Mirga, Editor at Large Views

The debate over 340B’s purpose recently spilled over into a Boston newspaper and nationally.

In a March 30 op-ed in the Boston Herald, Peter Pitts, a former U.S. Food and Drug Administration (FDA) official under President George W. Bush

Express Scripts Defends 340B Claims ID Requirement

April 8, 2021 Tom Mirga, Editor at Large Views

Express Scripts told 340B covered entities in recent letters that it has granted "numerous" extensions of time for pharmacies to comply with its new 340B claims identification process.

Pharmacy benefits manager Express Scripts (ESI) told a hospital group and an HIV/AIDS clinic in recent days that it has “already granted numerous pharmacies extensions” to its controversial new 340B claims identification requirement that went into effect March 1.

ESI

Panel Lauds Women’s Role in Creating and Leading 340B

April 6, 2021 Ron Shinkman Views

Participants in last week's Notable Women of 340B webinar included, clockwise from top left, Peggy Tighe, Colleen Meiman, Colleen DiClaudio, Marilyn Hayes, and Lorrie Carr.

(Updated Tuesday, April 6, 2021, 4:00 p.m. EDT—Individuals who were among CV340B’s Notable Women of 340B were excluded from the original version of this article. They have been added to the list at the end.)

Women have played a key

340B Groups Ask Express Scripts to Drop Claims Submission and ID Requirement

April 6, 2021 Tom Mirga, Editor at Large Views

The 340B Coalition told Express Scripts that covered entities cannot comply with its new 340B claims submission and identification requirement absent "a massive investment of financial and human resources." | Shutterstock

Groups representing 340B health care providers have asked pharmacy benefit manager Express Scripts (ESI) to stop making 340B providers and their contract pharmacies retrospectively submit and flag 340B claims in a way that has never been done before, and that

Survey: Pharma’s 340B Contract Pharmacy Actions are Putting the Squeeze on Hospitals

March 23, 2021 Ron Shinkman Views

Nearly all (97 percent) of all 340B hospitals in a recent survey said they are impacted by drug manufacturers' curbs on contract pharmacy use. | Shutterstock

340B hospitals are under significant pressure due to drug manufacturers ending 340B discounts on drugs dispensed by contract pharmacies, hospital advocacy group 340B Health says in its latest annual member survey.

Nearly 500 hospitals that are members of 340B

Health Care Reporter Foresees Federal Action on Drug Pricing, But Not Immediately

February 25, 2021 Tom Mirga, Editor at Large Views

Politico Pro reporter Sarah Owermohle told 340B Coalition winter conference attendees she thinks President Biden will turn to drug pricing after dealing first with the COVID-19 pandemic and bolstering the Affordable Care Act.

The U.S. Senate Finance Committee’s new Democratic chair is considering bringing back a bipartisan bill from the last session of Congress that would require drug manufacturers to pay the federal government rebates on Medicare Part B and Part D drugs

Biden Will Turn to Drug Pricing Once COVID-19 Ebbs, Shalala Predicts

February 19, 2021 Tom Mirga, Editor at Large Views

Former HHS Secretary Donna Shalala (right) holds her rescue dog, Fauci, at the end of her talk yesterday during the 340B Coalition winter conference.

President Biden will likely turn to lowering drug prices once the COVID-19 pandemic stops demanding so much of his attention, Donna Shalala, U.S. Health and Human Services (HHS) Secretary during both of President Clinton’s terms in office, predicted in a

Site Footer Live